The importance of being grade 3: WHO 1999 versus WHO 2004 pathologic grading

European Urology

Volumn 62, Issue 4, 2012, Pages 620-623

  Liedberg, Fredrik ^a   Lauss, Martin ^a   Patschan, Oliver ^a   Aine, Mattias ^a   Chebil, Gunilla ^b   Cwikiel, Magdalena ^a   Engilbertsson, Helgi ^a   Gudjonsson, Sigurdur ^a   Kollberg, Petter ^c   Sjödahl, Gottfrid ^a   Månsson, Wiking ^a   Lindgren, David ^a   Höglund, Mattias ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Unilabs   (France)

^c HELSINGBORG HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3;

BLADDER CANCER; CANCER GRADING; CANCER GROWTH; CANCER LOCALIZATION; CHROMOSOME ABERRATION; GENE; GENE EXPRESSION PROFILING; GENE MUTATION; HISTOPATHOLOGY; HUMAN; MUTATIONAL ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TRANSITIONAL CELL CARCINOMA; WORLD HEALTH ORGANIZATION;

EID: 84865688742     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.05.063     Document Type: Editorial

References (10)

1. M. Babjuk, W. Oosterlinck, and R. Sylvester EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update Eur Urol 59 2011 997 1008
2. A. Lopez-Beltran, F. Algaba, and D.M. Berney Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP) Histopathology 58 2011 579 585
3. C. Busch, and F. Algaba The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems Virchows Arch 441 2002 105 108
4. Sjödahl G, Lauss M, Lövgren K, et al. A molecular taxonomy for urothelial carcinoma. Clin Cancer Res. In press. http://dx.doi.org/10.1158/1078- 0432.CCR-12-0077-T
5. D. Lindgren, A. Frigyesi, and S. Gudjonsson Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome Cancer Res 70 2010 3463 3472
6. J. Zhao, J. Richter, and U. Wagner Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa) Cancer Res 59 1999 4658 4661
7. J. Richter, U. Wagner, and P. Schraml Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer Cancer Res 59 1999 5687 5691
8. Juanpere N, Agell L, Lorenzo M, et al. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer. Hum Pathol. In press. http://dx.doi.org/10.1016/j.humpath.2011.10.026
9. Cheng L, MacLennan G, Lopez-Beltran A. Histologic grading of urothelial carcinoma: a reappraisal. Human Pathol. In press. http://dx.doi.org/10.1016/j. humpath.2012.01.008
10. D.R. Rhodes, J. Yu, and K. Shanker Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression Proc Natl Acad Sci U S A 101 2004 9309 9314